Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Convergent effects of neurodevelopmental disorder-associated variants at mitochondria.

bioRxiv : the preprint server for biology·2026

Same author

Identification of Multiple Sulfatase Deficiency (MSD) in newborn screening: A case study.

Molecular genetics and metabolism reports·2026

Same author

Genetic insights on the mechanisms of human cortical folding.

bioRxiv : the preprint server for biology·2026

Same author

Female iPSC X-chromosome inactivation (XCI) erosion and its transcriptomic effects during CRISPR gene editing and neural differentiation.

bioRxiv : the preprint server for biology·2026

Same author

Sustainability of gap funding programs aimed at commercializing academic innovation.

Nature biotechnology·2026

Same author

Using Machine Learning and Predictive Artificial Intelligence to Determine Cage Change Frequency for Mice Housed in Individually Ventilated Cages and Drive Vivarium Operational Efficiency.

Journal of the American Association for Laboratory Animal Science : JAALAS·2025

Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026

Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026

Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026

Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026

Same journal

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Human mutation·2026

Same journal

Comment on "When the Outcome Contains the Exposure: Methodological Limits of a Genome-Wide Cross-Trait Analysis of Type 2 Diabetes and MASLD".

Human mutation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

Microarray-based mutation detection in the dystrophin gene.

Madhuri R Hegde¹, Ephrem L H Chin, Jennifer G Mulle

¹Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, USA. mhegde@genetics.emory.edu

|July 30, 2008

Summary

This summary is machine-generated.

A new high-resolution microarray assay accurately detects deletions and duplications in the dystrophin gene, improving diagnosis for Duchenne and Becker muscular dystrophies (DMD/BMD). This cost-effective method aids clinical molecular testing and carrier screening.

More Related Videos

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Related Experiment Videos

Last Updated: Jul 3, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Exon Skipping in Directly Reprogrammed Myotubes Obtained from Human Urine-Derived Cells

Published on: May 7, 2020

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Area of Science:

Genetics
Molecular Biology
Neuromuscular Disorders

Background:

Duchenne and Becker muscular dystrophies (DMD/BMD) are X-linked disorders caused by mutations in the dystrophin gene.
Mutations include deletions, duplications, and small variants, complicating diagnosis and carrier testing.
Existing diagnostic methods are time-consuming and may not accurately detect all mutation types, especially duplications.

Purpose of the Study:

To develop and validate a high-resolution comparative genomic hybridization (CGH) microarray assay.
To accurately detect both deletions and duplications in the dystrophin gene.
To provide a rapid, cost-effective diagnostic tool for DMD/BMD.

Main Methods:

Development and validation of a high-resolution CGH microarray.
Application of the microarray for detecting copy number variations in the dystrophin gene.
Comparison with existing diagnostic methodologies.

Main Results:

The developed CGH microarray assay accurately detects both deletions and duplications in the dystrophin gene.
The assay is shown to be effective for screening large genes like dystrophin.
It offers a more efficient and comprehensive diagnostic approach compared to current methods.

Conclusions:

A novel CGH microarray assay provides accurate and efficient detection of dystrophin gene deletions and duplications.
This method can be readily adopted by clinical molecular testing laboratories.
The assay improves diagnostic capabilities for DMD/BMD and facilitates carrier testing.